Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing

Intermediate-risk acute myeloid leukemia (IR-AML), which accounts for a substantial number of AML cases, is highly heterogeneous. Although several mutations have been identified, the heterogeneity of AML is uncertain because novel mutations have yet to be discovered. Here we applied next generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bianhong, Liu, Yangyang, Hou, Guangyuan, Wang, Lili, Lv, Na, Xu, Yuanyuan, Xu, Yihan, Wang, Xiuli, Xuan, Zhaoling, Jing, Yu, Li, Honghua, Jin, Xiangshu, Deng, Ailing, Wang, Li, Gao, Xiaoning, Dou, Liping, Liang, Junbin, Chen, Chongjian, Li, Yonghui, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077997/
https://www.ncbi.nlm.nih.gov/pubmed/27062340
http://dx.doi.org/10.18632/oncotarget.7028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077997/
https://www.ncbi.nlm.nih.gov/pubmed/27062340
http://dx.doi.org/10.18632/oncotarget.7028

Ejemplares similares